BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24840632)

  • 1. Analysis of urinary nucleosides as potential cancer markers determined using LC-MS technique.
    Struck-Lewicka W; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2014 Dec; 101():50-7. PubMed ID: 24840632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers.
    Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ
    J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
    Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of urinary nucleosides. V. Identification of urinary pyrimidine nucleosides by liquid chromatography/electrospray mass spectrometry.
    Bond A; Dudley E; Lemière F; Tuytten R; El-Sharkawi S; Brenton AG; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2006; 20(2):137-50. PubMed ID: 16331740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of urinary nucleosides. II. Comparison of mass spectrometric methods for the analysis of urinary nucleosides.
    Dudley E; Lemiere F; Van Dongen W; Langridge JI; El-Sharkawi S; Games DE; Esmans EL; Newton RP
    Rapid Commun Mass Spectrom; 2001; 15(18):1701-7. PubMed ID: 11555869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Hsu WY; Lin WD; Tsai Y; Lin CT; Wang HC; Jeng LB; Lee CC; Lin YC; Lai CC; Tsai FJ
    Clin Chim Acta; 2011 Sep; 412(19-20):1861-6. PubMed ID: 21740897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary modified nucleosides as tumor markers.
    Dudley E; Lemiere F; Van Dongen W; Esmans E; El-Sharkawi AM; Games DE; Brenton AG; Newton RP
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):987-9. PubMed ID: 14565327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic approach for determination of urinary nucleosides as potential tumor markers using electromigration techniques.
    Markuszewski MJ; Struck W; Waszczuk-Jankowska M; Kaliszan R
    Electrophoresis; 2010 Jul; 31(14):2300-10. PubMed ID: 20564268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of urinary nucleosides. I. Optimisation of high performance liquid chromatography/electrospray mass spectrometry.
    Dudley E; El-Sharkawi S; Games DE; Newton RP
    Rapid Commun Mass Spectrom; 2000; 14(14):1200-7. PubMed ID: 10918368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid and sensitive method for quantitation of nucleosides in human urine using liquid chromatography/mass spectrometry with direct urine injection.
    Lee SH; Jung BH; Kim SY; Chung BC
    Rapid Commun Mass Spectrom; 2004; 18(9):973-7. PubMed ID: 15116424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry.
    Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass spectrometry based methods for analysis of nucleosides as antiviral drugs and potential tumor biomarkers.
    Agrofoglio LA; Bezy V; Chaimbault P; Delépée R; Rhourri B; Morin P
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1523-7. PubMed ID: 18066819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of urinary nucleosides as helper tumor markers in hepatocellular carcinoma diagnosis.
    Jeng LB; Lo WY; Hsu WY; Lin WD; Lin CT; Lai CC; Tsai FJ
    Rapid Commun Mass Spectrom; 2009 Jun; 23(11):1543-9. PubMed ID: 19399767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted metabolomics: Liquid chromatography coupled to mass spectrometry method development and validation for the identification and quantitation of modified nucleosides as putative cancer biomarkers.
    Godoy AT; Eberlin MN; Simionato AVC
    Talanta; 2020 Apr; 210():120640. PubMed ID: 31987192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
    Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
    Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry.
    Cho SH; Jung BH; Lee SH; Lee WY; Kong G; Chung BC
    Biomed Chromatogr; 2006 Nov; 20(11):1229-36. PubMed ID: 16799933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.
    Li HY; Wang SM; Liu HM; Bu SS; Li J; Han D; Zhang MZ; Wu GY
    J Mass Spectrom; 2009 May; 44(5):641-51. PubMed ID: 19142897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
    Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
    Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of RP-HPLC columns used for determination of nucleoside metabolic patterns in urine of cancer patients.
    Waszczuk-Jankowska M; Markuszewski MJ; Markuszewski M; Kaliszan R
    Bioanalysis; 2012 Jun; 4(10):1185-94. PubMed ID: 22651562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
    An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
    J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.